Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Cancers|August 7, 2021
Glutamatergic Signaling a Therapeutic Vulnerability in MelanomaKevinn Eddy, Suzie ChenInternational Journal of Molecular Sciences|December 1, 2020
Overcoming Immune Evasion in MelanomaKevinn Eddy, Suzie ChenCancers|April 27, 2024
Current State of Melanoma Therapy and Next Steps: Battling Therapeutic ResistanceAnna Fateeva, Kevinn Eddy, Suzie ChenPigment Cell & Melanoma Research|December 8, 2023
Overview of current melanoma therapiesAnna Fateeva, Kevinn Eddy, Suzie ChenFrontiers in Oncology|February 22, 2021
Decoding Melanoma Development and Progression: Identification of Therapeutic VulnerabilitiesKevinn Eddy, Raj Shah, Suzie ChenCancers|December 13, 2016
Biology, Therapy and Implications of Tumor Exosomes in the Progression of MelanomaAllison L Isola, Kevinn Eddy, Suzie ChenOncotarget|February 9, 2018
Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasivenessAllison L Isola, Kevinn Eddy, Krzysztof Zembrzuski, et al.Cancer Research|April 17, 2019
Concurrent Targeting of Glutaminolysis and Metabotropic Glutamate Receptor 1 (GRM1) Reduces Glutamate Bioavailability in GRM1+ MelanomaRaj Shah, Simar J Singh, Kevinn Eddy, et al.Cells|September 23, 2022
Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and ProgressionKevinn Eddy, Mohamad Naser Eddin, Anna Fateeva, et al.JID Innovations : Skin Science From Molecules to Population Health|March 6, 2024
Assessing Longitudinal Treatment Efficacies and Alterations in Molecular Markers Associated with Glutamatergic Signaling and Immune Checkpoint Inhibitors in a Spontaneous Melanoma Mouse ModelKevinn Eddy, Kajal Gupta, Mohamad Naser Eddin, et al.Pageof 2